Understanding epigenetic remodeling in primordial germ cells

了解原始生殖细胞的表观遗传重塑

基本信息

  • 批准号:
    9261554
  • 负责人:
  • 金额:
    $ 31.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-02-05 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): During pregnancy three generations of DNA co-exist. Mum's, baby's and the germ line of baby. During the first and second trimester the majority of methylated cytosines from the DNA of baby's progenitor germ line cells, called primordial germ cells (PGCs) are removed. This act is essential to remove errors in methylation acquired during gametogenesis in the parents, and/or during early development of baby after fertilization. If errors in cytosine methylation are not removed, the abnormally methylated alleles have a risk of being inherited as disease epialleles in the following generation. Given that the environment can stably influence the genome, including the genome of baby's PGCs in utero, there is a need to understand the mechanisms that regulate DNA demethylation in PGCs in order to develop strategies to guard against the transmission of disease epialleles in future generations. Recently my group discovered that DNA demethylation in human PGCs is regulated in two phases however the mechanisms underlying demethylation globally (phase 1) and locally (phase 2) are unclear. In this project we aim to uncover new details on the dynamics of DNA demethylation in human PGCs and use conditional deletions of mouse PGCs in vivo as well as differentiation of mouse PGCs from embryonic stem cells in vitro to address hypotheses regarding the specific mechanisms responsible for demethylation in the mammalian germ line. In aim 1 we will identify the dynamic removal of cytosine methylation at base resolution for the very first time in human PGCs and address the hypothesis that Ubiquitin- like, containing PHD and RING finger domains, 1 (Uhrf1) repression by protein arginine methyltransferase 5 (Prmt5) is responsible for the phase 1 DNA demethylation in mammals. In aim 2 using a conditional deletion in mouse PGCs we will address the hypothesis that Dnmt1 maintains cytosine methylation at discreet loci in PGCs in the absence of its major cofactor Uhrf1. In aim 3, we turn to phase 2 demethylation to directly address the hypothesis that conversion of 5-methylcytosine to 5-hydroxymethylcytosine by Tet methylcytosine dioxygenases has a functional role in the demethylation of imprinting control centers in PGCs. Taken together, results from this grant will lead to new insights into the mechanisms that regulate germ line epigenetic inheritance, and in future work our goal will be to prevent epialleles from being acquired and transmitted.
描述(由申请人提供):在怀孕期间,三代DNA共存。妈妈的,婴儿的和婴儿的生殖系。在第一个和第二个三个月期间,来自婴儿的祖生殖系细胞(称为原始生殖细胞(PGCs))的DNA的大部分甲基化胞嘧啶被去除。这一行为对于消除在父母配子发生期间和/或在受精后婴儿早期发育期间获得的甲基化错误至关重要。如果胞嘧啶甲基化中的错误没有被去除,异常甲基化的等位基因有在下一代中作为疾病表观等位基因遗传的风险。考虑到环境可以稳定地影响基因组,包括子宫内婴儿PGC的基因组,有必要了解PGC中调节DNA去甲基化的机制,以制定防止疾病表观等位基因在后代中传播的策略。最近,我的小组发现,人类PGCs中的DNA去甲基化在两个阶段进行调节,但全球(第1阶段)和局部(第2阶段)的去甲基化机制尚不清楚。在这个项目中,我们的目标是发现新的细节,在人类PGCs的DNA去甲基化的动态和使用条件性删除小鼠PGCs在体内以及小鼠PGCs的分化,从胚胎干细胞在体外,以解决有关的特定机制,负责在哺乳动物生殖系去甲基化的假设。在目标1中,我们将首次在人类PGC中鉴定在碱基分辨率下胞嘧啶甲基化的动态去除,并解决蛋白质精氨酸甲基转移酶5(Prmt 5)抑制的含有PHD和RING指结构域的泛素样1(Uhrf 1)负责哺乳动物中1期DNA去甲基化的假设。在目标2中,使用小鼠PGC中的条件性缺失,我们将解决Dnmt 1在其主要辅因子Uhrf 1不存在的情况下维持PGC中离散位点的胞嘧啶甲基化的假设。在目标3中,我们转向2期去甲基化,以直接解决以下假设:通过泰特甲基胞嘧啶双加氧酶将5-甲基胞嘧啶转化为5-羟甲基胞嘧啶在PGCs中印迹控制中心的去甲基化中具有功能作用。总之,这项资助的结果将导致对调节生殖系表观遗传的机制的新见解,在未来的工作中,我们的目标将是防止表观等位基因被获得和传播。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amander Clark其他文献

Amander Clark的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amander Clark', 18)}}的其他基金

Towards a preclinical model for overcoming infertility with induced pluripotent stem cells
建立利用诱导多能干细胞克服不孕症的临床前模型
  • 批准号:
    10630112
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
  • 项目类别:
Towards a preclinical model for overcoming infertility with induced pluripotent stem cells
建立利用诱导多能干细胞克服不孕症的临床前模型
  • 批准号:
    10165771
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
  • 项目类别:
Towards a preclinical model for overcoming infertility with induced pluripotent stem cells
建立利用诱导多能干细胞克服不孕症的临床前模型
  • 批准号:
    10411980
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
  • 项目类别:
Cellular and Molecular Basis of Human Primordial Germ Cell Specification
人类原始生殖细胞规格的细胞和分子基础
  • 批准号:
    10396109
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
  • 项目类别:
Differentiating embryonic stem cells into developing germ line
将胚胎干细胞分化为发育中的种系
  • 批准号:
    9384658
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
  • 项目类别:
Cellular and Molecular Basis of Human Primordial Germ Cell Specification
人类原始生殖细胞规格的细胞和分子基础
  • 批准号:
    10613472
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
  • 项目类别:
Cellular and Molecular Basis of Human Primordial Germ Cell Specification
人类原始生殖细胞规格的细胞和分子基础
  • 批准号:
    10226094
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
  • 项目类别:
Differentiating embryonic stem cells into developing germ line
将胚胎干细胞分化为发育中的种系
  • 批准号:
    9174849
  • 财政年份:
    2014
  • 资助金额:
    $ 31.96万
  • 项目类别:
SCDB Meeting: "Innovations in Development"
SCDB会议:“发展中的创新”
  • 批准号:
    8400281
  • 财政年份:
    2012
  • 资助金额:
    $ 31.96万
  • 项目类别:
Epigenetic Regulation of Germ Cell Derivation from heSCs
heSC 生殖细胞衍生的表观遗传调控
  • 批准号:
    8379982
  • 财政年份:
    2012
  • 资助金额:
    $ 31.96万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 31.96万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 31.96万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 31.96万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 31.96万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 31.96万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 31.96万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 31.96万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 31.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了